The World Health Organization recognises antimicrobial resistance (AMR) as one of the most pressing global threats to medicine.
Without effective antibiotics, much of the success of modern medicine, such as the levels of unprecedented survival rates from major surgery or super effective, chemotherapy treatment, would be totally compromised. With our defences running out, where is the innovation and investment in the next generation of antibiotics? Who is stepping up to take on the challenge?
Click here to read the full article
Click here to view the article as a PDF